申请人:Merck Patent Gesellschaft mit beschrankter Haftung
公开号:US05532266A1
公开(公告)日:1996-07-02
Novel arylacetamides of the formula I ##STR1## in which Q is R.sup.4 --CH(CH.sub.2 Z)--NA--, ##STR2## R.sup.1 is Ar, cycloalkyl with 3-7 C atoms or C.sub.4 -C.sub.8 -cycloalkyl-C.sub.1 -C.sub.7 -alkyl, R.sup.2 is Ar, R.sup.3 is H, OH, OA or A, R.sup.4 is A or phenyl which can optionally be substituted once or twice by F, Cl, Br, I, OH, OA, CF.sub.3, NO.sub.2, NH.sub.2, NHA, NHCOA, NHSO.sub.2 A or NA.sub.2, R.sup.5 and R.sup.6 are each, independently of one another, H, F, Cl, Br, I, OH, OA, CF.sub.3, NH.sub.2, NHA, NA.sub.2, NHCOA, NHCONH.sub.2, NO.sub.2 or taken together are methylenedioxy, A is alkyl with 1-7 C atoms, and physiologically acceptable salts thereof.
式I的新型芳基乙酰胺化合物
##STR1##
其中Q是R.sup.4 --CH(CH.sub.2 Z)--NA--, ##STR2## R.sup.1是Ar,环烷基,具有3-7个碳原子或C.sub.4-C.sub.8-环烷基-C.sub.1-C.sub.7-烷基,R.sup.2是Ar,R.sup.3是H,OH,OA或A,R.sup.4是A或苯基,可以选择性地被F,Cl,Br,I,OH,OA,CF.sub.3,NO.sub.2,NH.sub.2,NHA,NHCOA,NHSO.sub.2A或NA.sub.2取代一次或两次,R.sup.5和R.sup.6分别是H,F,Cl,Br,I,OH,OA,CF.sub.3,NH.sub.2,NHA,NA.sub.2,NHCOA,NHCONH.sub.2,NO.sub.2或一起取代为亚甲二氧基,A是具有1-7个碳原子的烷基,以及其生理学上可接受的盐。